Bausch Health Companies (BHC) Expected to Announce Earnings on Wednesday

Bausch Health Companies (NYSE:BHC) is expected to post its quarterly earnings results after the market closes on Wednesday, February 19th. Analysts expect Bausch Health Companies to post earnings of $1.65 per share and revenue of $2.51 billion for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Bausch Health Companies Trading Down 3.6 %

Shares of Bausch Health Companies stock opened at $6.15 on Tuesday. The firm has a market cap of $2.22 billion, a P/E ratio of -12.82, a P/E/G ratio of 0.34 and a beta of 0.68. Bausch Health Companies has a 12 month low of $3.96 and a 12 month high of $11.46. The stock’s fifty day moving average price is $7.43 and its 200-day moving average price is $7.47.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Royal Bank of Canada cut their price target on Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating on the stock in a research note on Thursday, January 30th. Jefferies Financial Group reaffirmed a “hold” rating and set a $8.00 price objective (down previously from $12.00) on shares of Bausch Health Companies in a research report on Thursday, February 6th. Finally, StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a research report on Friday, October 25th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.